Lv11
58 积分 2025-03-14 加入
Antibody-oligonucleotide conjugates in cancer therapy: Potential and Promise
2小时前
已完结
Fragment-Based Anti-inflammatory Agent Design and Target Identification: Discovery of AF-45 as an IRAK4 Inhibitor to Treat Ulcerative Colitis and Acute Lung Injury
1个月前
已完结
Discovery of Rigid Linker-Based IRAK4 PROTACs with Improved Metabolic Stability for the Treatment of Inflammatory Diseases
1个月前
已完结
ABS0277 DISCOVERY AND CHARACTERIZATION OF SIM0711, A POTENT AND SELECTIVE IRAK4 PROTAC WITH ENHANCED EFFICACY AND SAFETY
1个月前
已关闭
Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degraders for Treating Inflammatory Diseases: Advances and Prospects
2个月前
已完结
Fragment-Based Anti-inflammatory Agent Design and Target Identification: Discovery of AF-45 as an IRAK4 Inhibitor to Treat Ulcerative Colitis and Acute Lung Injury
2个月前
已完结
Discovery of Rigid Linker-Based IRAK4 PROTACs with Improved Metabolic Stability for the Treatment of Inflammatory Diseases
2个月前
已完结
Discovery of LC-MI-3: A Potent and Orally Bioavailable Degrader of Interleukin-1 Receptor-Associated Kinase 4 for the Treatment of Inflammatory Diseases
2个月前
已完结
Discovery of APH02174 as a Highly Selective and Orally Bioavailable IRAK4 Degrader for the Treatment of Inflammatory Diseases
2个月前
已完结
PTPN2: Advances and perspectives in cancer treatment potential and inhibitor research
3个月前
已完结
皖公网安备34019202002308
